News

Neovasc Comments on European Heart Journal Publication

Report demonstrates objective improvements in patients suffering from microvascular dysfunctionVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 28, 2022)…

2 years ago

Beanfields Secures New Accounts; Boosh Hires Marsham Food Brokers For Continued Canadian Expansion

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or…

2 years ago

MDIC Publishes Framework on External Evidence Methods for Medical Devices

The Framework aims to assist stakeholders with use of new, innovative, and existing statistical methods for evidence fusion from data…

2 years ago

The Garage’s Population Health Management Platform, Bridge, earns ONC Health IT Certification from Drummond Group

ORLANDO, Fla.--(BUSINESS WIRE)--The Garage today announced that its platform Bridge has achieved Office of the National Coordinator for Health Information…

2 years ago

GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care

CHICAGO & DUBLIN--(BUSINESS WIRE)--Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians,…

2 years ago

Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test

VANCOUVER, BC / ACCESSWIRE / April 28, 2022 / Gemina Laboratories Ltd. (CSE:GLAB) (FRA:8I7) (the "Company" or "Gemina") is pleased…

2 years ago

Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022

ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's…

2 years ago

Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Third Quarter of Fiscal Year 2022 Results

EAGAN, MN / ACCESSWIRE / April 28, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,…

2 years ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update

- Executing on broad vaccine development program, with new clinical studies in COVID-19 and influenza together with GSK to validate…

2 years ago

Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age

Submission to Regulators Globally Is Based on Phase 2/3 Studies of mRNA-1273 in Young ChildrenCAMBRIDGE, MA / ACCESSWIRE / April…

2 years ago